Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Completed · Phase 2

Conditions studied: Liver Cancer

In brief

RATIONALE: Octreotide may stop or slow the growth of tumor cells and may be an effective treatment for liver cancer. PURPOSE: This phase II trial is studying how well octreotide works in treating patients with locally advanced or metastatic liver cancer.

Key facts

Study ID

NCT00257426

Run by

UNC Lineberger Comprehensive Cancer Center

People needed

31

Starts

2005-07-01

Expected to finish

2009-09-01

Last updated by the study team

2012-02-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• The University of North Carolina Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.